File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma

TitleUse of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma
Authors
Issue Date2008
PublisherAdis International Ltd. The Journal's web site is located at http://dermatology.adisonline.com/
Citation
American Journal Of Clinical Dermatology, 2008, v. 9 n. 6, p. 396-398 How to Cite?
AbstractSubcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma. The optimal therapy for SPTCL is undefined and the results of treatment with anthracycline-containing chemotherapy for aggressive cases have remained poor. A 27-year-old woman with multifocal and aggressive CD8+ SPTCL was treated with the purine analog fludarabine in combination with mitoxantrone and dexamethasone (FND). The patient achieved complete remission after one course of treatment. After completion of six courses of FND, the patient has remained in remission for more than 3 years. FND may be an effective treatment for aggressive SPTCL. © 2008 Adis Data Information BV. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/59254
ISSN
2015 Impact Factor: 3.084
2015 SCImago Journal Rankings: 1.485
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChim, CSen_HK
dc.contributor.authorLoong, Fen_HK
dc.contributor.authorNg, WKen_HK
dc.contributor.authorKwong, YLen_HK
dc.date.accessioned2010-05-31T03:46:15Z-
dc.date.available2010-05-31T03:46:15Z-
dc.date.issued2008en_HK
dc.identifier.citationAmerican Journal Of Clinical Dermatology, 2008, v. 9 n. 6, p. 396-398en_HK
dc.identifier.issn1175-0561en_HK
dc.identifier.urihttp://hdl.handle.net/10722/59254-
dc.description.abstractSubcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma. The optimal therapy for SPTCL is undefined and the results of treatment with anthracycline-containing chemotherapy for aggressive cases have remained poor. A 27-year-old woman with multifocal and aggressive CD8+ SPTCL was treated with the purine analog fludarabine in combination with mitoxantrone and dexamethasone (FND). The patient achieved complete remission after one course of treatment. After completion of six courses of FND, the patient has remained in remission for more than 3 years. FND may be an effective treatment for aggressive SPTCL. © 2008 Adis Data Information BV. All rights reserved.en_HK
dc.languageengen_HK
dc.publisherAdis International Ltd. The Journal's web site is located at http://dermatology.adisonline.com/en_HK
dc.relation.ispartofAmerican Journal of Clinical Dermatologyen_HK
dc.subject.meshAdulten_HK
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - therapeutic useen_HK
dc.subject.meshDexamethasone - administration & dosageen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHumansen_HK
dc.subject.meshLymphoma, T-Cell - drug therapy - pathologyen_HK
dc.subject.meshMaleen_HK
dc.subject.meshMiddle Ageden_HK
dc.subject.meshMitoxantrone - administration & dosageen_HK
dc.subject.meshPanniculitis - pathologyen_HK
dc.subject.meshSkin Neoplasms - drug therapy - pathologyen_HK
dc.subject.meshVidarabine - administration & dosage - analogs & derivativesen_HK
dc.titleUse of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphomaen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1175-0561&volume=9&issue=6&spage=396&epage=8&date=2008&atitle=Use+of+fludarabine-containing+chemotherapeutic+regimen+results+in+durable+complete+remission+of+subcutaneous+panniculitis-like+T-cell+lymphomaen_HK
dc.identifier.emailChim, CS:jcschim@hku.hken_HK
dc.identifier.emailKwong, YL:ylkwong@hku.hken_HK
dc.identifier.authorityChim, CS=rp00408en_HK
dc.identifier.authorityKwong, YL=rp00358en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.2165/0128071-200809060-00007en_HK
dc.identifier.pmid18973407-
dc.identifier.scopuseid_2-s2.0-55249101769en_HK
dc.identifier.hkuros158558en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-55249101769&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume9en_HK
dc.identifier.issue6en_HK
dc.identifier.spage396en_HK
dc.identifier.epage398en_HK
dc.identifier.isiWOS:000261125100006-
dc.publisher.placeNew Zealanden_HK
dc.identifier.scopusauthoridChim, CS=7004597253en_HK
dc.identifier.scopusauthoridLoong, F=6602794154en_HK
dc.identifier.scopusauthoridNg, WK=7401613493en_HK
dc.identifier.scopusauthoridKwong, YL=7102818954en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats